Phenotypic Heterogeneity among Tumorigenic Melanoma Cells from Patients that Is Reversible and Not Hierarchically Organized

Cancer Cell - Tập 18 - Trang 510-523 - 2010
Elsa Quintana1,2,3,4, Mark Shackleton1,2,3,4, Hannah R. Foster1,2,3,4, Douglas R. Fullen5, Michael S. Sabel6, Timothy M. Johnson7, Sean J. Morrison1,2,3,4
1Howard Hughes Medical Institute
2Life Sciences Institute
3Department of Internal Medicine
4Center for Stem Cell Biology
5Department of Pathology
6Department of Surgery
7Department of Dermatology, University of Michigan, Ann Arbor, MI 48109-2216, USA

Tài liệu tham khảo

Agliano, 2008, Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rgamma null mice generate a faster and more efficient disease compared to other NOD/SCID-related strains, Int. J. Cancer, 123, 2222, 10.1002/ijc.23772 Al-Hajj, 2003, Prospective identification of tumorigenic breast cancer cells, Proc. Natl. Acad. Sci. USA, 100, 3983, 10.1073/pnas.0530291100 Boiko, 2010, Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271, Nature, 466, 133, 10.1038/nature09161 Bonnet, 1997, Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell, Nat. Med., 3, 730, 10.1038/nm0797-730 Charles, 2010, Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells, Cell Stem Cell, 6, 141, 10.1016/j.stem.2010.01.001 Eisterer, 2005, Different subsets of primary chronic myeloid leukemia stem cells engraft immunodeficient mice and produce a model of the human disease, Leukemia, 19, 435, 10.1038/sj.leu.2403649 Frank, 2003, Regulation of progenitor cell fusion by ABCB5 P-glycoprotein, a novel human ATP-binding cassette transporter, J. Biol. Chem., 278, 47156, 10.1074/jbc.M308700200 Held, 2010, Characterization of melanoma cells capable of propagating tumors from a single cell, Cancer Res., 70, 388, 10.1158/0008-5472.CAN-09-2153 Hope, 2004, Acute myeloid leukemia originates from a hierarchy of leukemic stem cell classes that differ in self-renewal capacity, Nat. Immunol., 5, 738, 10.1038/ni1080 Hu, 2009, ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays, J. Immunol. Methods, 347, 70, 10.1016/j.jim.2009.06.008 Ito, 2002, NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells, Blood, 100, 3175, 10.1182/blood-2001-12-0207 Jamieson, 2004, Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML, N. Engl. J. Med., 351, 657, 10.1056/NEJMoa040258 Joo, 2008, Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas, Lab. Invest., 88, 808, 10.1038/labinvest.2008.57 Kleinsmith, 1964, Multipotentiality of single embryonal carcinoma cells, Cancer Res., 24, 1544 Lapidot, 1994, A cell initiating human acute myeloid leukemia after transplantation into SCID mice, Nature, 367, 645, 10.1038/367645a0 Mani, 2008, The epithelial-mesenchymal transition generates cells with properties of stem cells, Cell, 133, 704, 10.1016/j.cell.2008.03.027 Neering, 2007, Leukemia stem cells in a genetically defined murine model of blast-crisis CML, Blood, 110, 2578, 10.1182/blood-2007-02-073031 Nowell, 1976, The clonal evolution of tumor cell populations, Science, 194, 23, 10.1126/science.959840 O'Brien, 2007, A human colon cancer cell capable of initiating tumour growth in immunodeficient mice, Nature, 445, 106, 10.1038/nature05372 Ogden, 2008, Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas, Neurosurgery, 62, 505, 10.1227/01.neu.0000316019.28421.95 Oravecz-Wilson, 2009, Persistence of leukemia-initiating cells in a conditional knockin model of an imatinib-responsive myeloproliferative disorder, Cancer Cell, 16, 137, 10.1016/j.ccr.2009.06.007 Pinner, 2009, Intravital imaging reveals transient changes in pigment production and Brn2 expression during metastatic melanoma dissemination, Cancer Res., 69, 7969, 10.1158/0008-5472.CAN-09-0781 Quintana, 2008, Efficient tumour formation by single human melanoma cells, Nature, 456, 593, 10.1038/nature07567 Read, 2009, Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma, Cancer Cell, 15, 135, 10.1016/j.ccr.2008.12.016 Reya, 2001, Stem cells, cancer, and cancer stem cells, Nature, 414, 105, 10.1038/35102167 Ricci-Vitiani, 2007, Identification and expansion of human colon-cancer-initiating cells, Nature, 445, 111, 10.1038/nature05384 Roesch, 2010, A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth, Cell, 141, 583, 10.1016/j.cell.2010.04.020 Sanchez, 2009, A robust xenotransplantation model for acute myeloid leukemia, Leukemia, 23, 2109, 10.1038/leu.2009.143 Schatton, 2009, Antitumor immunity and cancer stem cells, Ann. N Y Acad. Sci., 1176, 154, 10.1111/j.1749-6632.2009.04568.x Schatton, 2008, Identification of cells initiating human melanomas, Nature, 451, 345, 10.1038/nature06489 Shackleton, 2009, Sources of heterogeneity in cancer: cancer stem cells versus clonal evolution, Cell, 138, 822, 10.1016/j.cell.2009.08.017 Sharma, 2010, A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations, Cell, 141, 69, 10.1016/j.cell.2010.02.027 Shultz, 2005, Human lymphoid and myeloid cell development in NOD/LtSz-SCID IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells, J. Immunol., 174, 6477, 10.4049/jimmunol.174.10.6477 Singh, 2004, Identification of human brain tumour initiating cells, Nature, 432, 396, 10.1038/nature03128 Wang, 2008, CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells, Int. J. Cancer, 122, 761, 10.1002/ijc.23130 Yilmaz, 2006, Pten dependence distinguishes hematopoietic stem cells from leukemia-initiating cells, Nature, 441, 475, 10.1038/nature04703